EXTON, PA / ACCESSWIRE / November 12, 2024 / Frontage Laboratories, Inc ., a global CRO, and Medicover Integrated Clinical ...

such as the first lab to offer full gene sequencing of the cystic fibrosis gene, multi-gene panels for intellectual ...

Q3 2024 Earnings Call Transcript November 7, 2024 Pacific Biosciences of California, Inc. beats earnings expectations.

Global Breast Cancer Screening Tests Market was valued at approximately USD 2.93 billion in 2023 and is projected to grow with a healthy CAGR of 54.3% over the forecast period 2024-2032. Read the ...

Global Cardiovascular Genetic Testing Market is valued at approximately USD 9.07 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 11.2% over the forecast period ...

The catalogue of genetic factors that have been implicated in kidney disease continues to grow. In this guide to gene–disease relationships, the authors discuss the crucial process whereby ...

Out of the 30 companies tracked by 360Dx, 22 saw their share prices decline, seven saw their stock prices increase, and one company’s shares remained essentially flat.

NEW YORK – Devyser announced Monday that its Devyser Compact genetic test for fetal abnormalities has received Class III approval from China's National Medical Products Administration. Separately, the ...

If you’ve had genetic testing, you might choose to share the results with your family members. If a family member has had genetic testing, you may be interested in knowing their results. When you ...

Myriad Genetics (MYGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus ...